IDEAYA Biosciences (IDYA) Misses Q4 EPS by 149c
Tweet
Share
E-mailGet Alerts IDYA Hot Sheet
Join SI Premium – FREE
IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($1.49). Revenue for the quarter came in at $7 million.
For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Laser Photonics regains NASDAQ compliance after filing quarterly report
- Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
